MiniMed Group (NASDAQ:MMED) Sets New 12-Month Low – Time to Sell?

Shares of MiniMed Group Inc (NASDAQ:MMED) reached a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $11.10 and last traded at $11.16, with a volume of 578097 shares trading hands. The stock had previously closed at $11.57.

Analyst Ratings Changes

A number of research firms have recently issued reports on MMED. Zacks Research upgraded MiniMed Group to a “hold” rating in a research note on Thursday, April 9th. Deutsche Bank Aktiengesellschaft began coverage on MiniMed Group in a research note on Tuesday, March 31st. They issued a “buy” rating and a $20.00 price target on the stock. BTIG Research began coverage on MiniMed Group in a research note on Tuesday, March 31st. They issued a “buy” rating and a $25.00 price target on the stock. Wall Street Zen upgraded MiniMed Group to a “hold” rating in a research note on Saturday, March 14th. Finally, Morgan Stanley began coverage on MiniMed Group in a research note on Tuesday, March 31st. They issued an “overweight” rating and a $19.00 price target on the stock. Eleven research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $22.45.

MiniMed Group Stock Down 3.5%

The firm has a 50 day simple moving average of $14.48.

About MiniMed Group

We are a scaled global medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. Since our founding more than 40 years ago, we have pioneered groundbreaking innovation and served the needs of our customers across the globe in service of our mission to make every day a better day for people with diabetes. Today, we are the only player in the market that commercializes all parts of an integrated diabetes management system.